Skip to main content

Application & Review

Initial application, post-approval activities, meetings & fees

Application

Policies, guidance, and processes relating to ethical review and oversight of Clinical and Behavioural research studies undertaken by BC Cancer researchers can be found on this website, as well as the UBC Office for Research Ethics website at: https://ethics.research.ubc.ca/.  

If you have any questions, please contact:  reb@bccancer.bc.ca


Post-approval

Please see  section IV– Study Amendments at:

 

https://ethics.research.ubc.ca/clinical-research-ethics/creb-guidance-notes/post-approval-guidance-notes

 

Please note that Amendments requiring REB full board review/approval must be submitted by the deadline for a full board meeting (see Meetings & Fees tab for meetings/deadlines).


Questions? email reb@bccancer.bc.ca 

Please see section III – Annual Renewals at:

 

https://ethics.research.ubc.ca/clinical-research-ethics/creb-guidance-notes/post-approval-guidance-notes

 

The pdf document below is to help determine whether full board review or expedited review of an annual renewal submission is required. This also indicates when a study no longer requires annual renewal and reporting of Serious Adverse Events (SAEs), and when a study can be considered complete (at which time a completion of study notice must be submitted to the REB in RISe).

Quick Reference Table for Annual Renewal & SAE Reporting & Completion of Study  (Oct 18, 2012)


Please note that Annual renewals requiring full board review/approval must be submitted by the deadline for a full board meeting (see Meetings & Fees tab for meetings/deadlines).

 

http://www.bccancer.bc.ca/our-research/ethics-oversight/research-ethics-board/application-review


Questions? email reb@bccancer.bc.ca 

Please see section VII – Submitting Unanticipated Problems at:

 

https://ethics.research.ubc.ca/clinical-research-ethics/creb-guidance-notes/post-approval-guidance-notes


Questions? email reb@bccancer.bc.ca  

Meetings & Fees

2020 Submission Deadlines and Meeting Dates for Full Board Review


MonthSubmission DeadlinesMeeting Dates
JanuaryJan 7
Jan 28
FebruaryFeb 4
Feb 25
MarchMar 3
Mar 24
AprilApr 7
Apr 28
MayMay 5
May 26
JuneJun 2
Jun 23
JulyJul 7
Jul 28
AugustAug 4
Aug 25
SeptemberSep 1
Sep 22
OctoberOct 6
Oct 27
NovemberNov 3
Nov 24
December*Nov 20
Dec 8

Jan 2021                  Jan 5                         Jan 26


*Reminder:  No new studies reviewed at December meeting (only renewals, amendments, or response to deferral)

Please note: We strictly adhere to deadlines.  


New applications 

Applications requiring full board review (e.g., new applications, deferral responses, PAAs, etc.) must be received in the REB inbox (i.e., already approved by the Department Head) prior to midnight on the deadline date to be considered for that month’s meeting. 


If applicable, the initial review fee must be submitted prior to or along with the application (see below for information on fees). Applications received after the midnight deadline or without fees will be deferred until the next month's meeting or until payment is received in full.


Please submit new applications at least 3 days prior to the deadline to allow for department head approval.

Submit minimal risk projects for delegated review  at any time (no deadline or meeting dates).


Annual Renewals

Annual Renewals requiring full board review should be submitted by the deadline date for the applicable full board meeting for review prior to the expiry date. 


Annual Renewals requiring expedited review should be submitted 2 weeks prior to expiry. 


Questions? email reb@bccancer.bc.ca 


BC Cancer Research Ethics Fees.pdf


Refunds: Once the REB has commenced review processes, a refund is not available. If an application is withdrawn prior to review, a refund is only available upon request. A refund under these circumstances is not automatically issued - the Principal Investigator must notify the REB by email to request a refund and include an explanation for the withdrawal. The email must include the REB #, project title, and the details for the refund such as the BC Cancer account into which the refund should be transferred or identification of the designate to whom the cheque is to be made payable.


Tab Heading
SOURCE: Application & Review ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2020 Provincial Health Services Authority